CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-25 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −14,854 | $86.63 | $1.3M | 0 |
| 2022-05-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +126,126 | $103.57 | $13.1M | 460,959 |
| 2022-05-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −126,126 | $140.12 | $17.7M | 334,833 |
| 2022-05-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +156,282 | $86.63 | $13.5M | 491,115 |
| 2022-05-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −156,282 | $140.12 | $21.9M | 334,833 |
| 2022-05-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −126,126 | $103.57 | $13.1M | 10,037 |
| 2022-05-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −156,282 | $86.63 | $13.5M | 14,854 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +34,898 | $103.57 | $3.6M | 369,731 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −33,898 | $140.12 | $4.7M | 335,833 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −800 | $141.54 | $113K | 335,033 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −200 | $142.26 | $28K | 334,833 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion | +42,568 | $86.63 | $3.7M | 377,401 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −41,268 | $140.12 | $5.8M | 336,133 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −1,000 | $141.51 | $142K | 335,133 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Sale | −300 | $142.24 | $43K | 334,833 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −34,898 | $103.57 | $3.6M | 136,163 |
| 2022-05-23 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Exercise or conversion · Non-Qualifed Stock Option (right to buy) | −42,568 | $86.63 | $3.7M | 171,136 |
| 2022-05-18 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Shares withheld for taxes | −8 | $136.98 | $1K | 32,006 |
| 2022-05-18 | WILENSKY GAIL R Director | Grant or award | +1,292 | 19,137 | ||
| 2022-05-18 | Doi Tracey Director | Grant or award | +1,292 | 2,209 |
Page 30 of 42 · 826 trades